George L. Chen

发表

Response: X-chromosome inactivation and autoimmunity

J. Prchal, George L. Chen, 2007 .

Carfilzomib for treatment of refractory chronic graft vs. host disease: A Chronic GVHD Consortium pilot phase II trial.

B. Storer, J. Pidala, Stephanie J. Lee, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Host-Derived CD70 Suppresses Murine Graft-versus-Host Disease by Limiting Donor T Cell Expansion and Effector Function

J. Ashwell, Jingxin Qiu, P. McCarthy, 2017, The Journal of Immunology.

X-linked clonality testing: interpretation and limitations.

J. Prchal, George L. Chen, 2007, Blood.

W. Wood, B. Storer, J. Pidala, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.

B. Narasimhan, J. Zehnder, D. Miklos, 2012, Blood.

The Chronic Graft-vs.-Host Disease Failure-Free Survival (cGVHD-FFS) index.

B. Storer, J. Pidala, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic Graft-versus-Host Disease.

B. Storer, J. Pidala, Stephanie J. Lee, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Design and Patient Characteristics of the Chronic Graft-versus-Host Disease Response Measures Validation Study.

J. Pidala, Stephanie J. Lee, M. Flowers, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Anti-Platelet-Derived Growth Factor Receptor Alpha Chain Antibodies Predict for Response to Nilotinib in Steroid-Refractory or -Dependent Chronic Graft-Versus-Host Disease.

D. Miklos, B. Storer, Jingxin Qiu, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

T Cell–Derived CD70 Delivers an Immune Checkpoint Function in Inflammatory T Cell Responses

Kelvin P Lee, Jingxin Qiu, P. McCarthy, 2017, The Journal of Immunology.

Dextramer reagents are effective tools for quantifying CMV antigen‐specific T cells from peripheral blood samples

P. Wallace, P. McCarthy, J. Tario, 2014, Cytometry. Part B, Clinical cytometry.

Immune profiling in Diffuse Large B-Cell Lymphoma and Mantle Cell Lymphoma Patients treated with Autologous Hematopoietic Cell Transplant

P. Wallace, F. Hernandez-Ilizaliturri, E. Repasky, 2019, Bone Marrow Transplantation.

Hematopoietic Cell Transplantation, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.

Y. Nieto, V. Bhatt, A. El-Jawahri, 2020, Journal of the National Comprehensive Cancer Network : JNCCN.

Early versus Late Pre-emptive Allogeneic Hematopoietic Cell Transplantation (p-alloHCT) for Relapsed or Refractory Acute Myeloid Leukemia (AML)

G. Deeb, S. Sait, P. McCarthy, 2015 .

Acute GVHD Diagnosis and Adjudication in a Multicenter Trial: A Report From the BMT CTN 1202 Biorepository Study

J. Bolaños-Meade, Yi-Bin Chen, J. Hansen, 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late acute graft-versus-host disease: a prospective analysis of clinical outcomes and circulating angiogenic factors.

W. Wood, B. Storer, J. Pidala, 2016, Blood.

β2-adrenergic receptor activation on donor cells ameliorates acute GvHD.

E. Repasky, Jingxin Qiu, P. McCarthy, 2020, JCI insight.

Remestemcel-L for acute graft-versus-host disease therapy

P. McCarthy, George L. Chen, P. Paplham, 2014, Expert opinion on biological therapy.

Organ Changes Associated with Provider-Assessed Responses in Patients with Chronic GVHD

B. Storer, J. Pidala, Stephanie J. Lee, 2019 .

Progressive chronic lymphocytic leukemia after allogeneic hematopoietic cell transplantation.

A. Desai, P. McCarthy, M. Ross, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

BPX-501 T cells interfere with minimal residual disease evaluation of B-cell acute lymphoblastic leukemia

P. Wallace, M. Borowitz, P. McCarthy, 2018, Bone Marrow Transplantation.

Erythropoietin receptor signaling regulates both erythropoiesis and megakaryopoiesis in vivo.

J. Prchal, G. Spangrude, Xiaosong Huang, 2010, Blood cells, molecules & diseases.

Granzyme B–Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease

Jingxin Qiu, P. McCarthy, T. Hahn, 2015, The Journal of Immunology.

This information is current as Acute Graft-versus-Host Disease T Cells Inhibits Murine + Death of CD 4 Mediated Activation-Induced − Granzyme

Jingxin Qiu, George L. Chen, N. Leigh, 2015 .

A Randomized Phase II Crossover Study of Imatinib or Rituximab for Cutaneous Sclerosis after Hematopoietic Cell Transplantation

W. Wood, D. Miklos, B. Storer, 2015, Clinical Cancer Research.

Methionine restriction selectively targets thymidylate synthase in prostate cancer cells.

D. Epner, B. Kwabi-Addo, Sha Lu, 2003, Biochemical pharmacology.

Polycythemia vera and its molecular basis: an update.

J. Prchal, George L. Chen, 2006, Best practice & research. Clinical haematology.

Housing Temperature–Induced Stress Is Suppressing Murine Graft-versus-Host Disease through β2-Adrenergic Receptor Signaling

J. Farrar, E. Repasky, Jingxin Qiu, 2015, The Journal of Immunology.

Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.

H. Gómez, Bing-he Xu, M. Desilvio, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Late Acute and Chronic Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation.

W. Wood, J. Pidala, Stephanie J. Lee, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced-Intensity Conditioning with Fludarabine, Melphalan, and Total Body Irradiation for Allogeneic Hematopoietic Cell Transplantation: The Effect of Increasing Melphalan Dose on Underlying Disease and Toxicity.

G. Wilding, A. Hutson, P. Wallace, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Impact of conditioning regimen on peripheral blood hematopoietic cell transplant

Anurag K. Singh, P. Wallace, P. McCarthy, 2019, World journal of clinical oncology.

A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies

D. Miklos, Jingxin Qiu, M. Flowers, 2011 .

Amphiregulin modifies the Minnesota Acute Graft-versus-Host Disease Risk Score: results from BMT CTN 0302/0802.

W. Wood, J. Pidala, E. Holler, 2018, Blood advances.

This information is current as Signaling-Adrenergic Receptor 2 β Disease through Suppressing Murine Graft-versus-Host Induced Stress Is − Housing Temperature

J. Farrar, E. Repasky, Jingxin Qiu, 2015 .

Infection Rates among Acute Leukemia Patients Receiving Alternative Donor Hematopoietic Cell Transplantation.

M. Norkin, M. Boeckh, M. Aljurf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Biomarker Panel for Chronic Graft-Versus-Host Disease.

Philip R. Gafken, Y. Ogata, B. Storer, 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Optical Coherence Tomography for Quantifying Human Cutaneous Chronic Graft-versus-Host Disease.

Chulhong Kim, P. McCarthy, T. Hahn, 2021, Transplantation and cellular therapy.

Nonrelapse mortality among patients diagnosed with chronic GVHD: an updated analysis from the Chronic GVHD Consortium

J. Pidala, Z. DeFilipp, Stephanie J. Lee, 2021, Blood advances.

Low-level Cytomegalovirus Antigenemia Promotes Protective Cytomegalovirus Antigen Specific T-Cells after Allogeneic Hematopoietic Cell Transplantation.

P. Wallace, P. McCarthy, J. Tario, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Initial therapy for chronic graft-versus-host disease: analysis of practice variation and failure-free survival

J. Pidala, Stephanie J. Lee, M. Arora, 2021, Blood advances.

High Rates of Transplantation in the Phase III Sierra Trial Utilizing Anti-CD45 (Iodine) 131I-Apamistamab (Iomab-B) Conditioning with Successful Engraftment and Tolerability in Relapsed Refractory (R/R) Acute Myeloid Leukemia (AML) Patients after Lack of Response to Conventional Care and Targeted Th

M. Berger, P. Hari, K. van Besien, 2022, Transplantation and Cellular Therapy.

Clinical Experience in the Randomized Phase 3 Sierra Trial: Anti-CD45 Iodine (131I) Apamistamab [Iomab-B] Conditioning Enables Hematopoietic Cell Transplantation with Successful Engraftment and Acceptable Safety in Patients with Active, Relapsed/Refractory AML Not Responding to Targeted Therapies

M. Berger, P. Hari, J. Pagel, 2021, Blood.

Durable discontinuation of systemic therapy in patients affected by chronic graft-versus-host disease

J. Pidala, Stephanie J. Lee, M. Arora, 2022, Haematologica.

Serological Response to Vaccination after Autologous Transplantation for Multiple Myeloma Is Associated with Improved Progression-Free and Overall Survival.

A. Merz, M. Merz, P. McCarthy, 2021, Transplantation and cellular therapy.

IgG Allotypes Reveal That Antimicrobial Humoral Immunity Persists after Reduced-Intensity Hematopoietic Cell Transplantation

Julie R. Boiko, D. Miklos, B. Sahaf, 2008 .

Rituximab Infusion Two Months after HCT Decreases Alloreactive B Cell Responses While Recipient Plasma Cells Persist.

Julie R. Boiko, D. Miklos, B. Sahaf, 2008 .

Managing cardiac amyloidosis: Auto or allotransplant?

P. McCarthy, T. Hahn, M. Ross, 2011, American journal of hematology.

Immune signatures associated with improved progression-free and overall survival for myeloma patients treated with AHSCT.

P. Wallace, B. Paiva, S. Holstein, 2017, Blood advances.

Idiopathic myelofibrosis without dacryocytes.

J. Prchal, U. Popat, T. Coetzer, 2006, Haematologica.

Amphiregulin Improves Stratification of the Refined Minnesota Acute Graft-Versus-Host Disease Risk Score: Results from BMT CTN 0302/0802

W. Wood, J. Pidala, E. Holler, 2017 .

Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemia.

P. Wallace, G. Deeb, S. Sait, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

NCCN Guidelines® Insights: Hematopoietic Cell Transplantation, Version 3.2022.

J. Bolaños-Meade, Y. Nieto, A. El-Jawahri, 2023, Journal of the National Comprehensive Cancer Network : JNCCN.

Impact of Molecular Features of Diffuse Large B-Cell Lymphoma on Treatment Outcomes with Anti-CD19 Chimeric Antigen Receptor (CAR) T-Cell Therapy

S. Dave, G. Bhagat, F. Hernandez-Ilizaliturri, 2021, Blood.

Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America.

G. Abel, W. Wood, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

QIM19-142: Development of a Low Resource Tool for Improving Head and Neck Cancer Treatment Delivery Within an Integrated Health Care Delivery System

A. Sabichi, V. Sandulache, Scott Charnitsky, 2019, The Journal of the National Comprehensive Cancer Network.

391: Rituximab Infusion after Allogeneic HCT Prevents Donor B Cell Reconstitution and Alloimmunity One Year Post Transplant

Julie R. Boiko, D. Miklos, B. Sahaf, 2008 .

Replicated Risk Index of Patient Functional Status Prior to Allogeneic Hematopoietic Cell Transplant Predicts Healthcare Utilization and Survival.

S. Rehman, P. McCarthy, T. Hahn, 2021, Transplantation and cellular therapy.

Acute Gvhd Diagnosis and Adjudication in a Multicenter Trial – a Report from the BMT CTN 1202 Biorepository Study

Yi-Bin Chen, J. Hansen, W. Saber, 2019, Biology of Blood and Marrow Transplantation.

Identification of neurotoxicity after chimeric antigen receptor (CAR) T-cell infusion without deterioration in the immune effector cell encephalopathy (ICE) score.

P. McCarthy, T. Hahn, M. Ross, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Targeted Conditioning of Iomab-B (131I-anti-CD45) Prior to Allogeneic Hematopoietic Cell Transplantation Versus Conventional Care in Relapsed or Refractory Acute Myeloid Leukemia (AML): Preliminary Feasibility and Safety Results from the Prospective, Randomized Phase 3 Sierra Trial

M. Berger, J. Pagel, H. Lazarus, 2018, Blood.

Short term storage of mobilized peripheral blood stem cells in a closed system changes the microenvironment and may affect the quantity of CD34+ and CD34+CD38-CD45RA-CD90+ cells: Effect of airtight storage on HSCs.

P. McCarthy, O. Maguire, H. Minderman, 2022, Transplantation and cellular therapy.

Randomized trial of lapatinib versus placebo added to paclitaxel in the treatment of human epidermal growth factor receptor 2-overexpressing metastatic breast cancer.

H. Gómez, Bing-he Xu, M. Desilvio, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Quantifying MHC dextramer-induced NFAT activation in antigen-specific T cells as a functional response parameter.

P. Wallace, P. McCarthy, O. Maguire, 2017, Methods.

Patient-reported treatment response in chronic graft-versus-host disease.

J. Pidala, A. Im, M. Flowers, 2023, Haematologica.

A phase 1 study of imatinib for corticosteroid-dependent/refractory chronic graft-versus-host disease: response does not correlate with anti-PDGFRA antibodies.

D. Miklos, Jingxin Qiu, M. Flowers, 2011, Blood.

Prophylactic rituximab after allogeneic transplantation decreases B-cell alloimmunity with low chronic GVHD incidence.

B. Narasimhan, J. Zehnder, D. Miklos, 2012, Blood.

X-linked clonality testing: interpretation and limitations.

J. Prchal, George L. Chen, 2007, Blood.